By Thapelo Molefe
South Africa has incorporated a new HIV testing strategy into routine public healthcare to help clinicians quickly determine whether a patient’s treatment is failing because of drug resistance or because they have not been taking their medication consistently.
The strategy, developed through the Intensified Treatment Evaluation and Monitoring Approach (ITREMA-2) study, uses a blood test to check whether the HIV medicine dolutegravir is present in a patient’s system when their viral load increases.
For the full story, click the link below.
